Home Azacitidine Administration in High Risk Myelodysplastic Syndromes: Favorable Results of a Pilot Study in 48 PatientsSylvestre Guillevic, Odile Beyne‐Rauzy, Jonathan Khalifa et al.|Blood|2011Cited by 1